Cyclophosphamide 2 g/100mL (Cyclophosphamide INJECTION, POWDER, FOR SOLUTION) 2 g/100mL

Cyclophosphamide 2 g/100mL is a potent medication used for various therapeutic purposes. This powder for solution is administered intravenously or orally, offering flexibility in treatment. Learn more about its uses and effects.

Strength

2 g/100mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3255-94) / 100 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Sandoz Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cyclophosphamide is primarily used as an antineoplastic agent, often in cancer treatments. It works by slowing or stopping the growth of cancer cells. Additionally, it may be used for certain autoimmune conditions. The specific uses of Cyclophosphamide 2 g/100mL can vary based on individual patient needs and medical advice.

Side Effects

Common effects of Cyclophosphamide may include nausea, vomiting, and hair loss. Some patients may experience fatigue or changes in appetite. These effects can vary in intensity and duration. Always consult a healthcare provider for personalized information.

Precautions & Warnings

Cyclophosphamide should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions. Pregnant women and individuals with certain medical conditions should exercise caution. Always store and dispose of Cyclophosphamide properly to ensure safety.

Avoid Interactions

Cyclophosphamide may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain foods may also affect its efficacy. Always consult a healthcare provider for personalized advice.

Frequently Asked Questions

Cyclophosphamide is primarily used as an antineoplastic agent in cancer treatments and for certain autoimmune conditions.

Cyclophosphamide 2 g/100mL can be administered intravenously or orally, depending on the specific treatment plan.

Common side effects may include nausea, vomiting, hair loss, fatigue, and changes in appetite.

Yes, Cyclophosphamide may interact with other medications, especially those that suppress the immune system.

Cyclophosphamide should be stored according to the manufacturer's instructions to ensure its stability and efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.